Odyssey Group International Inc (ODYY)

[cabos_tacos]

Have you tried to call investor relations?

I've been trying for almost a week

straight to a recording every time

you might be buying stock in a company that has already shut down their office

1 702 780 6559

0.085 on a 9700 shares traded.. ameritrade calling it a "heavy day..."

you said just bought 30k at 0.95 this morning ? hummmmm

[midtownmurphy]

Had a bid for 50k yesterday @.09 but didn't get any. Thanks to the peep for giving me the 30k @.095 this morning $ODYY!!!

[cabos_tacos]

Still sitting on a bunch ... but you dont need mine, theres plenty for sale on ameritrade..lets just say with volumes under 30k, if i put all i had up for sale, it would crash the PPS :)

[midtownmurphy]

Cabo what do you have left? I'll gladly take it from you $ODYY

[Zorax]

Not sure but it looks like they're shuffling new names and stock around to protect what they had.

All they've done is create a new website to go with the new name, but I don't think I've found any SEC or finra reports that show a name change. Nothing so far.

https://otce.finra.org/otce/dailyList

[cabos_tacos]

Have you tried to call investor relations?

went straight to a recording

1 702 780 6559


im selling 5k at a time.. so far 10k off today

[Zorax]

They appear to be a rental for use mail drop group office in a bank building where you pay for a mail box and office front. Usually can rent an office for meetings.
Would be interesting to be in Nevada and drop by. No name on main outside board.

2300 W Sahara Ave 800 4012, Las Vegas, NV 89102

https://goo.gl/maps/ZGdCac9Xn777miSK9

[Zorax]

Possibly suspicious. No real products, template stock photo website, always claims in development, changed their name, only four employees all shareholders. No real way to check on products. A paid for created website not a real company make.

https://stockanalysis.com/stocks/odyy/company/

https://www.odysseyhealthinc.com/

Not going into this right now, but wondering if the name change corresponds to SEC investigation.

[cabos_tacos]

should have made it yesterday.. I've sent 3 emails to IR past couple of weeks .. nada

[Zorax]

One would think if this is one of the targeted companies, they should be making a public statement today or next week.

[Zorax]

Ah no. They're a scam. Total complete scam. 4 people owned 90% of the stock and suckered traders. Live and learn.
These guys ring a bell? Seems like they did some musical chairs last 6 months.
Or these guys used a complete match name scam.
Upon further research, it appears these crooks targeted real companies and odyssey itself may not be a scam. Later discovery should settle the matter. Normally a company has more knowledge of its stock and issue. The companies may still be questionable. One can never really be sure in the pinks.

SEC Obtains Over $1 Million Final Judgment Against Three Individuals in Microcap Fraud Scheme Targeting Retail Investors
Litigation Release No. 25689 / April 5, 2023
Securities and Exchange Commission v. Matthew Nicosia, William Reininger, Fabrizio Di Carlo, and Ronald Touchard, Civ. Action, o. 1:22-cv-05761 (E.D.N.Y. filed Sept. 27, 2022)

On April 4, 2023, the U.S. District Court for the Eastern District of New York entered final judgments against Utah resident Matthew Nicosia and California residents William ("Rocky") Reininger, and Ronald Touchard whom the SEC had charged for their roles in a microcap fraud scheme targeting retail investors. Among other things, the judgment orders the defendants to pay a total of over $1.2 million.

https://www.sec.gov/litigation/litreleases/2023/lr25689.htm?utm_medium=email&utm_source=govdelivery

[cabos_tacos]

Nothing since September..Two reasons. Nothing is actually happening or taking the high road, their PR person sucks .


9/28/22
Odyssey Health, Inc. Announces Successful Completion of Phase I Clinical Trial for Concussion Drug


Convertible Promissory Note
This AMENDMENT (this “Amendment”) is entered into by and between Company and Holder (each as defined below), effective as of March
31, 2023 (the “Effective Date”), binding on the undersigned parties as of that date.
RECITALS
Odyssey Group Intl, Inc. (“Company”) and LGH Investments, LLC (“Holder”) entered into that certain Convertible Promissory Note (the
“Note”) dated April 5, 2021 in the amount of $1,050,000.00 (the “Loan Amount”). Capitalized terms not otherwise defined have the meaning set forth in
the Note.
WHEREAS, the parties have agreed to extend the maturity date of the Note subject to the conditions contained herein.
AGREEMENT
NOW, THEREFORE, in consideration of the mutual covenants and agreements herein contained and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the parties hereto agree as follows:
1. Extension of Maturity Date. The Maturity Date of the Note is amended and extended to June 30, 2023.
2. Compensation for Extension. In exchange for the extension of the Maturity Date, $20,000.00 shall be added to the principal amount
outstanding on the Note between the Company and Holder as of the Effective Date hereof.
3. Effectiveness; Conflict. Except as modified hereby, the Note and terms thereof shall remain in full force and effect. On and after the
effectiveness of this Amendment, each reference in the Notes to “this Agreement,” “hereunder,” “hereof,” “herein” or words of like import shall mean and
be a reference to the Note, as amended by this Amendment. To the extent the terms of this Amendment conflict with any provision of the Note or any of the
documents referenced therein, then the provisions of this Amendment shall control.
4. Counterparts. This Amendment may be executed by facsimile transmission and in counterparts, each of which shall be deemed an original,
but all of which together shall constitute one and the same agreement.

[midtownmurphy]

Great lotto ticket to have-:) $ODYY

[cabos_tacos]

i can only loses 3700 more if it goes goes to zero.. why not go down with the ship at this point? anyone have anything positive to say about this ? even the family is now calling it a lotto ticket ... frustrating

[LoneGrey]

I've added down here to bring my average down. Is it a good move for me? Too early to tell. I believe we could see some good things come here though. Hope so anyway.

[cabos_tacos]

In perfect world Abbott buys our lotto ticket?

[midtownmurphy]

That lottery ticket might look even better

UPDATE 1-U.S. FDA clears Abbott's blood test for concussions
Tue, March 7, 2023, 9:30 AM EST
In this article:

ABT
-1.72%
Watchlist

Watchlist
Performance Outlookyahoo plus badge
2W-6W
6W-9M
9M+
(Adds details, background)

March 7 (Reuters) - The U.S. Food and Drug Administration has cleared Abbott Laboratories' blood test that would help doctors assess traumatic brain injury (TBI), commonly known as concussions, the company said on Tuesday.

The clearance marks the first commercially available laboratory blood test for TBI, according to the company, helping the doctors to rule out need for a CT scan in patients with mild TBI.

TBIs are caused by blow or whiplash to the head and can pose risk of short- and long-term effects that can include impairment of memory and movement.

Abbott already has a plasma test for TBI and was cleared by the FDA in 2021.

The new test measures two indicators in the blood that, in elevated concentrations, are tightly correlated to brain injury, the company said. (Reporting by Raghav Mahobe in Bengaluru; Editing by Shailesh Kuber)

[cabos_tacos]

.10 cents ?Looks the cavalry isn't coming...I added at .48 one legged man in one of those contests


First lottery ticket I ever bought

[cabos_tacos]

If ODYY goes belly up i figure I can only lose another 5 grand on top of the huge loss I'm sitting on , so WTF?

I no longer feel this is an investment.. I'm looking at as a lotto ticket.

I sleep better that way

[midtownmurphy]

Absolutely, and it may even before they announce Phase 2 :-}

[cabos_tacos]

NFL concussions up because of increased examinations, commissioner says
By Alex Butler, 8 hrs ago
UPI News
UPI News
Follow
PHOENIX, Feb. 8 (UPI) -- The number of NFL player concussions increased during the 2022-23 season because of the league's increased examinations of head injuries, commissioner Roger Goodell said at his annual Super Bowl news conference Wednesday in Phoenix. https://share.newsbreak.com/30l6hehe

https://share.newsbreak.com/30l6tdn5

[cabos_tacos]

You think when they announce Phase 2 we should see a massive short squeeze

[LoneGrey]

I'm here too. Been buying .16's and below. And holding for better things to come. If they ever come? The only drug in the world to treat concussion, passed phase 1 trials and here we sit waiting for someone to finance us through phase 2. Hard to stay bullish when nothing seems to be moving forward but I still do believe.

[midtownmurphy]

No you're not the only one

Historical Short Volume Data for ODYY
Date Close High Low Volume Short Volume % of Vol Shorted
Feb 02 NA NA NA 460,750 232,200 50.40
Feb 01 NA NA NA 15,100 12,500 82.78
Jan 31 NA NA NA 114,771 97,850 85.26
Jan 30 NA NA NA 59,563 20,610 34.60
Jan 27 NA NA NA 86,850 33,360 38.41
Jan 26 NA NA NA 45,877 13,500 29.43
Jan 25 NA NA NA 151,107 41,156 27.24
Jan 24 NA NA NA 108,820 43,305 39.80
Jan 23 NA NA NA 100,772 56,106 55.68
Jan 20 NA NA NA 48,716 7,668 15.74
Jan 19 NA NA NA 88,613 27,613 31.16
Jan 18 NA NA NA 239,207 137,999 57.69
Jan 17 NA NA NA 49,645 7,000 14.10
Jan 13 NA NA NA 112,543 33,110 29.42
Jan 12 NA NA NA 110,701 58,551 52.89
Jan 11 NA NA NA 46,386 31,262 67.40
Jan 10 NA NA NA 49,317 22,318 45.25
Jan 09 NA NA NA 26,249 750 2.86
Jan 06 NA NA NA 70,991 33,446 47.11
Jan 05 NA NA NA 39,429 19,030 48.26
Jan 04 NA NA NA 75,922 37,850 49.85

[cabos_tacos]

Anyone averaging down here?

Am I the only one left still in ?

[cabos_tacos]

Insider dumps 50,000 shares

Today PPS .19

Who does that looking at a gold mine ?

[Artestkid]

ODYY has been backing and filling nicely over the past few months.. Huge volume late last year.. went to mid 30's .. then tested 11 again.. currently 28-30/share. For those who are bearish... the FDA would not have approved Phase 1 on Prevacus II.. the concussion drug submission. Company also has Medical Devices that they have acquired and CEO Redmond has an impressive CV in the Pharma Industry.

[cabos_tacos]

Financial Statements
Balance sheet
No balance sheet information available.

Income statement
No income statement information available.

Cash flow
No cash flow information available.

[cabos_tacos]

I added at ,47
This morning ? .13

Let’s hope this is tax selling

[cabos_tacos]

received my proxy yesterday.. i voted against giving any of those execs getting pay raises...


coaches pay should be performance based.. execs likewise

[cabos_tacos]

.14

i see either a reverse split or an offering before more moving up a phase

thankfully playing with money i can afford to lose

[cabos_tacos]

.15

[midtownmurphy]

From todays news states credit line of $10 million!!

ODYSSEY HEALTH, INC. PROVIDES UPDATE ON COMPANY AND THE PROGRESS OF CONCUSSION DRUG DEVELOPMENT

Las Vegas, Nevada, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, today presents a Company update and recap of its concussion drug development program. Concussions represent an ‘unmet’ medical need and affect tens of millions worldwide.

Odyssey acquired the intellectual property and all rights to the concussion drug in March 2021. Since the acquisition, Odyssey has added key industry experts to its management, made significant progress in the drug development program, and completed a Phase I human clinical trial. Key successes include:

Adding two key executives to the management team that have pertinent pharmaceutical experience bringing drugs through the clinical process and to the market.
Completion of FDA-required IND enabling studies for a Phase I human trial. This work was performed in partnership with multiple GMP/GLP third party vendors.
Development of a nanoparticle spray-dried formulation for intranasal delivery to enhance brain uptake. This work was performed in partnership with our UK partner under GMP regulations.
Development and GMP manufacture of our novel breath-propelled intranasal delivery device with our California based engineering partner.
Patent application filed for our novel breath-propelled intranasal delivery device.
Contracted with world-class contract research organizations, Avance Clinical Pty, Ltd. and Nucleus Networks to conduct the Phase I clinical trial.
Excellent compliance of our breath-propelled intranasal delivery device in the Phase I trial.
Completion of the Phase I human clinical trial, proving the drug is safe and well tolerated.
Phase I human clinical trial showed no drug accumulation through the 10-day patient follow-up visit.
Ongoing drug stability at elevated temperatures showing no degradation
Raised over $5 million to support the company and its development efforts and access to an equity line with Lincoln Park Capital for up to $10 million.

[cabos_tacos]

7.9 million ?

Please provide a link.

This is what they are reporting

In thousands
2022. 2021. 2020. 2019
Total Assets 569.677 610.533 105.584 23,661

[cabos_tacos]

I hope you’re right murph

[midtownmurphy]

Cabo their reporting insinuates that ODYY was the recipient of TANF funds. That is patently false. Next the drug passed Phase 1. If the drug wasn't pliable, they wouldn't be allowed into Phase 2 Human trials, that is factual info! Their false and misleading lies are hurting our value and we have damages!!JMHO

[cabos_tacos]

The truth doesn’t matter these days . Perception is everything .. people believe what the see on tv and social media .. one just has to look at trump to see it ..

Good luck with the lawsuit

Unless ODDY can issue a press release saying they are lawyering up it could get very ugly .if they remain silent, the perception will be it’s all true



What are you going to sue them for ?

Fact is ,u til it’s FDA approved , it is unproven ….good luck

I

[midtownmurphy]

I'm also consulting with an Attorney today in NYC about a class-action suit for shareholders against ESPN, NBC and Phalanx. They can't get away with publishing false and misleading stories!!

[midtownmurphy]

LOL I did listen to the "analyst" report. He states the Company has "no money"! He obviously didn't do his fact checking either! It's in their filings that they have an $8,000,000.00 LOC from Lincoln Park with approx $7.9 MILLION left as of last filing!!! I think ODYY should sue them all for their LIES!!!

[cabos_tacos]

You might want to skip to 15:44 on the broadcast and listen to the analyst give his opinion on ODDY

“Better off buying a lottery ticket “.

That person next to Farve? Do you recognize him ?

If you don’t think this will tank the PPS even lower you are living on another planet
That went all around the world ..

[midtownmurphy]

Favre and Prevacus have NOTHING to do with ODYY! ODYY acquired the drug from Prevacus FACT!! NBC and ESPN didn't do any "fact checking" before running their story. We know it's not FDA approved, that's why they're moving into Phase 2 studies!! Look at the company filings ie FORM 3 and 4's, due you see Brett Favre's name?? He's not the "biggest shareholder " as the media is reporting. Totally false story. JMHOand keeping with the FACTS!!

[midtownmurphy]

Favre and the Company Prevacus have NOTHING to do with ODYY. ODYY acquired the drug from Prevacus. NBC and ESPN didn't do any "fact checking" before running their story. they have a "hard on " for Brett Favre!! As far as efficacy, that's why they're in clinical trials. When Phase 2 is complete i'll bet they will change their tune...I'm sticking to the facts JMHO

[cabos_tacos]

More

The company that is now trying to bring the drug to market, Odyssey Health, appears to be on shaky financial ground, according to public filings. Experts in neuroscience and drug development say its promise to conduct human trials of the drug in Mississippi — supposedly an economic development benefit — appears unlikely to ever be fulfilled.

“You’re better off buying a lottery ticket,” said David Maris, a New Jersey-based financial analyst who specializes in pharmaceuticals and who examined financial statements for NBC News. “It’s destined to be a zero.”


https://share.newsbreak.com/2cmrjle4

[cabos_tacos]

Going to be a blood bath
In the morning

[cabos_tacos]

Farve and Prev on the NBC news right now

You know , broadcast worldwide

Questioning the effectiveness

Ugly , very ugly

F@@king great

PPS. .17

Tell me how this isn’t relevant again

[24jg]

Their goal is Nasdaq listing next year.

[midtownmurphy]

I wouldn't know. I'm sure it will be disclosed in the next 10Q. Like what i'm seeing $ODYY

[cabos_tacos]

Was the compensation package these folks were offered ?

Almost has to be stock .

[midtownmurphy]

$ODYY Expanding the team!!!

Odyssey Health Inc. Strengthens Commitment to Odyssey NeuroPharma Through Expansion of Executive Team

Las Vegas, Nevada, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc. (the "Company" or "Odyssey"), a medical technology company focused on developing unique, life-saving medical products, is pleased to announce its continued commitment to the newly formed entity, Odyssey NeuroPharma, with the expansion of its executive team.

Joining the executive team at Odyssey NeuroPharma to advance Odyssey’s concussion treatment, and Niemann-Pick treatment, is Erik Emerson as Chief Commercial Officer and Greg Gironda as Chief Operating Officer. Mr. Emerson and Mr. Gironda have over 50 years of collective pharmaceutical experience in commercializing innovative pharmaceutical compounds with leading pharmaceutical companies.

“Odyssey NeuroPharma is dedicated to addressing the unmet medical needs in traumatic brain injury. Erik and Greg will provide the proven experience and expertise needed to bring this novel treatment through clinical trials and ultimately to commercial launch,” said Michael Redmond, CEO of Odyssey Health.

“The team at Odyssey is committed to bringing solutions to a devastating but poorly understood issue. The opportunity to impact the lives of our military, elderly, children, and athletes was something that one can only hope for in our careers.” Mr. Erik Emerson continued, “mild traumatic brain injury and the subsequent long-term effects are a true urgency. Joining the team at this critical juncture to lead our conversion of strong early science, to potential patient availability is unique.

Concussions effect all segments of our society, with over 5 million occurrences annually in the U.S. alone. Currently, there are no FDA approved treatments available. Odyssey Neuropharma is planning a Phase II program, which will evaluate efficacy in support of its extensive safety and animal data.

About Odyssey Health Inc. (formerly Odyssey Group International, Inc.)

Odyssey Health Inc. (OTC: ODYY) is a medical company with a focus in life-saving medical products and solutions. Odyssey's corporate mission is to create, acquire and develop distinct assets, intellectual property, and exceptional technologies that provide meaningful medical solutions. The Company is focused on areas that have an identified technological advantage, provide superior clinical utility, and have a substantial market opportunity. For more information, visit the Company’s website at www.odysseyhealthinc.com

We encourage our shareholders to visit our corporate social media accounts for updates:

https://twitter.com/OdysseyHealth1

https://www.facebook.com/odysseyhealthinc

https://www.linkedin.com/company/odysseyhealthinc

https://www.youtube.com/channel/UCsS--v0od_fYIBu2tvqmj9Q

About Odyssey NeuroPharma Inc.

Odyssey NeuroPharma, Inc., is a wholly-owned subsidiary of Odyssey Health Inc. and focused on developing drugs to treat neurological disorders. The blood-brain barrier (“BBB”) represents a significant obstacle for drug delivery to the brain. Many drugs have failed in neuroscience research due to the inability to jump the hurdle that is the BBB. The Odyssey NeuroPharma will use its unique intranasal delivery device coupled with its powdered formulations to let drugs be delivered more directly to the brain, providing for efficient and quick delivery. This targeted approach requires less drug to accomplish neuroprotection further reducing drug levels in the plasma which reduces side effects.

Forward-Looking Statements

This news release may have forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements because of various factors and uncertainties, including our ability to continue to raise needed funds, complete the Phase II trial, our ability to develop products, rapid changes in our markets, changes in demand for our future products, and legislative, regulatory, competitive developments and general economic conditions.

Inquiries:

Odyssey Health
[e-mail]

https://www.globenewswire.com/newsroom/ti?nf=ODY4ODM5NSM1MjQxNDg0IzUwMDA4NjI2NA==
https://ml.globenewswire.com/media/ZGE4YjRlNzktYzdjMC00ZDU3LWJjZGItNjc3ZTRkODQ3ZThmLTUwMDA4NjI2NA==/tiny/Odyssey-Health-Inc.png

[24jg]

https://www.crunchbase.com/person/jacob-vanlandingham